BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 183446)

  • 21. [The mechanism of action of bencyclane on smooth musculature].
    Kukovetz WR; Pöch G; Holzmann S; Paietta E
    Arzneimittelforschung; 1975 May; 25(5):722-6. PubMed ID: 170943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function.
    Ponari O; Civardi E; Dettori G; Magha A; Potì R; Bulletti G
    Arzneimittelforschung; 1976; 26(8):1532-8. PubMed ID: 12770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of fludilat on carbohydrate metabolism].
    Hockwin O
    Fortschr Med; 1977 Aug; 95(29):1837-40. PubMed ID: 885465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of bencyclane-hydrogen-fumarate on the carbohydrate metabolism of bovine lens homogenates.
    Hockwin O; Korte I; Loth C; Ohrloff C; Fuss R; Schmidt G
    Arzneimittelforschung; 1977 Jul; 27(7):1417-20. PubMed ID: 578465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of no-shpa, halidor, dibazol and euphylline on the fibrinogen content and fibrinolytic activity of blood].
    Ivleva AIa; Kremneva VF; Zolotukhin SI
    Farmakol Toksikol; 1976; 39(3):304-8. PubMed ID: 1026513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M; D'Angelo A; Mannucci PM; Pareti F; Vanasia S; Viganò
    Clin Ter; 1980 Feb; 92(4):359-68. PubMed ID: 6108818
    [No Abstract]   [Full Text] [Related]  

  • 27. Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.
    Störmer B; Kleinschmidt K; Loose D; Kremer K
    Curr Med Res Opin; 1977; 4(8):588-95. PubMed ID: 872611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of bencyclane fumarate on brain metabolism in the rat--in vitro study].
    Cavallini L; Lucchetti G
    Boll Chim Farm; 1977 Aug; 116(8):473-83. PubMed ID: 921852
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect on platelet functions of derivatives of cyclic nucleotides.
    Pareti FI; Carrera D; Mannucci L; Mannucci PM
    Thromb Haemost; 1978 Apr; 39(2):404-10. PubMed ID: 209573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic and fibrinolytic effect of bencyclane.
    Kovács IB; Csalay L; Csákváry G
    Arzneimittelforschung; 1971 Oct; 21(10):1553-6. PubMed ID: 5171885
    [No Abstract]   [Full Text] [Related]  

  • 33. [Animal experiments on the vasoactive properties of Bencyclane in the blood supply of organs].
    Castenholz A; Dammer L
    Med Welt; 1979 Feb; 30(8):285-91. PubMed ID: 423750
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of bencyclane on the cerebral vascular resistance in normal and impaired acid-base status].
    Hutten H; Vaupel P
    Med Welt; 1977 Sep; 28(39):1567-72. PubMed ID: 927111
    [No Abstract]   [Full Text] [Related]  

  • 35. [Proceedings: Inhibitory effect of bencyclane (Fludilat) on disaccharidase activities in the mucosa of the small intestine of the rat].
    Frisius H; Heidrich H; Brauer D
    Z Gastroenterol; 1976 Mar; 14 Suppl():255. PubMed ID: 960945
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral therapy with bencyclane. Changes in blood-flow characteristics and spontaneous thrombocyte aggregation during oral therapy with bencyclane].
    Völker D
    ZFA (Stuttgart); 1979 Jan; 55(3):182-7. PubMed ID: 419814
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of platelets in glomerulonephritis.
    George CR; Clark WF; Cameron JS
    Adv Nephrol Necker Hosp; 1975; 5():19-65. PubMed ID: 242207
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inhibition of cholinesterases by bencyclane in vitro].
    Mányai S; Koch E; Cseh JR; Budai Z; Pallos L
    Pharmazie; 1978 Jun; 33(6):361-5. PubMed ID: 684052
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of bencyclane, flunarizine and naftidrofuryl on a calorically induced long time nystagmus (author's transl)].
    Scherer H; Schmidtmayer E; Hirche H
    Laryngol Rhinol Otol (Stuttg); 1978 Aug; 57(8):773-8. PubMed ID: 308146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.